At Memorial Sloan Kettering (MSK), we're not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we're driving excellence and improving outcomes. We're treating cancer, one patient at a time. Join us and make a difference every day.
In compliance with applicable New York and New Jersey State regulatory authorities, COVID-19 vaccination (2 doses of either the Pfizer or Moderna vaccine or one dose of the Johnson & Johnson vaccine) is mandatory for all MSK employees, contingent workers, and volunteers. Exceptions are permitted for those employees who request and receive an approved medical or fully remote exemption.
*Staff working at a MSK New Jersey location must be up to date with COVID-19 vaccination, which includes having completed the primary COVID-19 vaccination series and booster once eligible as mandated by New Jersey State. All New Jersey staff not yet eligible for a booster must receive a booster within 3 weeks of becoming eligible as a condition of continued employment at MSK.
Note: Individuals are eligible to receive a COVID-19 booster five months after receiving the second dose of either the Pfizer or Moderna vaccine or two months after the J&J vaccine.
Memorial Sloan Kettering Cancer Center (MSK) is one of the world's premier cancer centers, committed to exceptional patient care, leading-edge research, and superb educational programs. The institution is a comprehensive cancer center whose purposes are the treatment and control of cancer, the advancement of biomedical knowledge through laboratory and clinical research, and the training of scientists, physicians and other health care workers.
The Levine lab is seeking a highly motivated and successful individual with a background in biology, genomics and prior experience or interest in bioinformatics. The lab focuses on investigating how genomic alterations give rise to hematologic malignancies. This includes investigation of mechanisms that drive disease initiation, progression, and response to therapy, at the gene and pathway level. As well, we have a focus on pre-clinical investigation of novel therapeutic approaches that have potential for translation into the clinic.
Our group is highly collaborative, both within MSK and outside. The candidate will become part of a diverse and multi-disciplinary team of students, postdocs and research technicians in our research group.
Investigation of mechanisms of TP53 mutant leukemogenesis.
Evaluation of biomarkers of therapeutic response in Myeloproliferative Neoplasms (MPNs).
Investigation of mechanisms of disease progression in MPNs.
Pre-clinical investigation of Novel mechanism-based therapeutic strategies in myeloid malignancies.
The ideal candidate should have:
A Ph.D. or M.D./Ph.D. in genetics, molecular biology, cancer biology, or related field.
Training in bioinformatics
Excellent oral and written communication skills
Collaborative skills and the ability to work in a team
Ability to perform self-directed and guided research
Please send CV, a letter outlining your interest and names/contact information of three references via email to:
Raajit Rampal email@example.com
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.
At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes. For the 28th year, MSK has been named a top hospital for cancer by U.S. News & World Report. We are proud to be on Becker’s Healthcare list as one of the 150 Great Places to Work in Healthcare in 2018, as well as one of Glassdoor’s Employees’ Choice Best Place to Work for 2018. We’re treating cancer, one patient at a time. Join us and make a difference every day.